Clinical #Pharmacogenomics Specialist at MedStar Health & Assistant Prof at Georgetown University Medical Center. he/him

Washington, DC
Joined April 2013
Our recent work describes the evidence for #PGx-guided pain management to improve pain control and reducing opioid misuse. We also provide a “how to” guide to demystify the process. buff.ly/3z59tMx The idea to write this paper started with a discussion in the @pkpdpg PRN
Optimizing pain management through genotype-guided approaches may ultimately provide safer and more effective therapy for pain control while decreasing the risk for opioid misuse. buff.ly/3z59tMx @MaxPGx @roseanngammal @jim_omics @UFPersonalMed @UFPharmacy
2
10
1
26
Congrats to @MaxPGx who received the “Excellence in Advancing Pharmacogenomics Through Collaboration” award from @AmSocietyPharm! The award honors leaders for driving #PGx advancements by fostering collaboration across disciplines/organizations/sectors. pharmacytimes.com/view/strip…
1
1
3
98
New clinical trial results! Ribociclib is used to treat certain breast cancers. We knew CYP3A inhibitors increase ribo levels by 3-fold. But does CYP3A5 genotype predict ribociclib levels? In short, no. A reassuring result for patients and clinicians. @GeorgetownCPC @pgrnhub
The LEANORA study: PKs and pharmacogenomics of ribociclib in Black patients with breast cancer. 🔑No association between CYP3A5 and ribociclib exposure (= no need for dose adjustments). Thank you, @ConquerCancerFd and @BCRFcure, for making this possible! rdcu.be/dVwuF
1
4
6
424
.@MaxPGx and colleagues assessed appraoches to pre-chemotherapy testing for dihydropyrimidine dehydrogenase deficiency (DPYD) in the US. Their take-away? Routine DPYD testing requires coordinated healthcare team effort. doi.org/10.1007/s00520-024-0… @MedStarResearch @MASCC_JSCC
1
4
177
Happy to present these data today and work with a great team @IlanaSchlam @SandraSwainMD @GeorgetownCPC
Excited to share the findings of the LEANORA trial, thank you @ConquerCancerFd and @BCRF for supporting this study! 🔑No association between CYP3A5 genotype and ribociclib exposure among Black participants @SandraSwainMD @ASCO #ASCO24 @OncoAlert
1
6
209
Oncologists are interested in #Pharmacogenomics and believe it can improve cancer care! Read more in this Future Medicine (@futuresciencegp) paper from Beth Peshkin, @schwartm, @NadiaAshai, @SandraSwainMD, @MaxPGx, and colleagues. doi.org/10.2217/pgs-2023-016… @MedStarResearch #PGx
2
3
191
We asked oncology providers in our health system about PGx. It is important to stratify based on whether they typically prescribe that drug (figure). Providers with previous PGx education were more likely to have ordered a test (OR: 7.9; 95% CI: 1.1–56) futuremedicine.com/doi/10.22…
2
4
375
Must read article on pharmacogenetics in cancer. DPYD Testing: Time to Put Patient Safety First. Call for @NCCN & @ASCO guidelines to incorporate testing prior to treatment with fluoropyrimidines. ascopubs.org/doi/10.1200/JCO… @gabe_a_brooks @mcleodhoward @JCO_ASCO
3
34
4
71
17,997
Post-test interruptive alerts were the most common CDS approach described. However, effectiveness varied greatly: Clinical response: 12-73% Alert response: 21-98% CDS is collection of tools and saying "we use CDS" should raise more questions than answers.
3
2
81
Happy to discuss the pharmacist's role in PGx implementation at the Precision Medicine Leaders Summit. @UFPharmacy @GenomeWeb
1
5
331
Key takeaway from the Precision Medicine Leaders Summit? The future is now. @pmlsummit @GenomeWeb @UFPharmacy @MaxPGx @JaiPatelPharmD @SanfordHealth @AtriumHealth @MedStarHealth @TAMUpharmacy @TAMU_IBT @TAMUHealth
5
1
15
1,044
Happy to contribute to this work that calls upon the @NCCN @US_FDA & @ASCO to recommend DPYD testing when prescribing 5-FU and capecitabine. @cpicpgx #PGx ascopubs.org/doi/full/10.120…
2
5
2
23
3,267
Recent collab with @WilliamFigg1 (@theNCI) where we comment on a recent trial and describe the current evidence & resources for #opioid pharmacogenetics #PGx. @NCCN Adult Cancer Pain guidelines support PGx testing @cpicpgx #TwitteRx @pgrnhub pubmed.ncbi.nlm.nih.gov/3671…
2
8
411
A great article for anyone wondering how to counsel patients on PGx testing or how others do it.
New #research from ACCP PK/PD/PG PRN members Teresa Ho, @roseanngammal, and @DunnenbergerPGX addresses the important topic of effective patient counseling approaches when communicating panel-based #pharmacogenetics results. Full article available at: academic.oup.com/ajhp/advanc…
1
6
21
Mark your calendars and join us for journal club: Tuesday, June 7th from 8-9:15 pm EST Registration link for the session is: lnkd.in/gAFjMh5S Link to Articles: lnkd.in/gFQtEwye lnkd.in/g-XNzY7K
1
3
1
3